WILLIAM SIMPSON: Open Payments
NPI 1437574134 · CHICKAMAUGA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 39 payments from 16 companies in 2025. Trend: 2023 $1,916 · 2024 $847 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $395 |
| Novo Nordisk Inc | 3 | $159 |
| Lundbeck LLC | 4 | $117 |
| PFIZER INC. | 5 | $116 |
| ABBVIE INC. | 4 | $84 |
| Antares Pharma, Inc. | 2 | $57 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Medtronic, Inc. | 1 | $44 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
Products named: AIRSUPRA, Ozempic, BREZTRI, REXULTI, XYOSTED, GVOKE HYPOPEN, MINIMED 780G, QULIPTA.
Industry payments across GA — which companies pay providers there.
